Table 2.
Measurement methods used in the literatures
| Domain | Related concept | Measurement methods (N: number of studies reporting) |
|---|---|---|
| psychosocial | Quality of life |
Dermatology Life Quality Index (DLQI) (N = 32) European Quality of Life-5 Dimensions (EQ-5D) (N = 7) Short Form Health Survey (SF-36) (N = 2) General Health Questionnaire (GHQ) (N = 1) World Health Organization Quality of Life-BREF (N = 1) Short form of the General Health Questionnaire (GHQ-28) (N = 1) Short-Form 12 health status instrument (N = 1) Eczema Quality of Life Scale (EQOLS) (N = 1) Revised Dyadic Adjustment Scale (R-DAS) (N = 1) |
| Subjective Burden |
Skindex-29 (N = 2) Skindex-16 (N = 2) Skindex-19 (N = 1) |
|
| psychological | Anxiety and depression |
Hospital Anxiety and Depression Scale (HADS) (N = 13) Beck Depression Inventory (BDI) (N = 8) 42-item Depression, Anxiety and Stress Scale (DASS-42) (N = 2) Social Anxiety Questionnaire (SAQ) (N = 2) Center for Epidemiologic Studies Depression Scale (CES-D) (N = 2) Self-Rating Depression Scale (SDS)&Self-Rating Anxiety (SAS) (N = 1) Patient Health Questionnaire Depression Scale (PHQ-9) (N = 1) Generalized Anxiety Disorder Scale (GAD-7) (N = 1) Arabic version of the Depression, Anxiety and Stress Scale (N = 1) Penn State Worry Questionnaire (N = 1) State-Trait-Anxiety Inventory (N = 1) |
| Body image |
Body Emotions Scale (BES) (N = 2) Appearance Schemas Inventory-Revised (ASI-R) (N = 2) Body Image Scale (BIS) (N = 2) Body Dysmorphic Disorder Questionnaire (BDDQ) (N = 1) Female Genital Self-image Score (FGSIS) (N = 1) Acceptance of Life with the Disease Scale (ALDS) (N = 1) Perceived Health Status (PHS) (N = 1) Multidimensional Body-Self Relations Questionnaire (MBSRQ) (N = 1) Skin Satisfaction Questionnaire (SSQ) (N = 1) Derriford Appearance Scale (DAS-24) (N = 1) |
|
| Self-esteem |
Rosenberg Self-esteem Scale (RSES) (N = 5) Fears of Compassion Scales (FCS) (N = 1) Brief Fear of Negative Evaluation Scale (Brief FNE) (N = 1) |
|
| Stigmatization |
Stigmatization Scale (N = 3) Stigmatization and Psoriasis Questionnaire (SPQ) (N = 1) Psoriasis disease stigma questionnaire (PSQ) (N = 1) Internalized Stigma Scale (ISS) (N = 1) |
|
| Alexithymia | Toronto Alexithymia Scale (TAS) (N = 1) | |
| social | Social support |
Berlin Social Support Scales (BSSS) (N = 1) Social support rating scale (SSS) (N = 1) Disease-Related Social Support Scale (DRSS) (N = 1) Multidimensional Scale of Perceived Social Support (MSPSS) (N = 1) |
| Social interaction |
Social Readjustment Rating Scale (N = 1) Participation Scale Questionnaire (N = 1) |
|
| Social acceptance | Marlowe–Crowne Social Desirability Scale (MC-SDS) (N = 1) | |
| Occupational effect |
Work Productivity and Activity Impairment (WPAI) (N = 4) Work Productivity and Activity Impairment Questionnaire: Psoriasis (WPAI-PSO) (N = 1) Work Productivity and Activity Impairment-General Health (WPAI-GH) (N = 1) Work Limitation Questionnaire (WLQ) (N = 1) Total work productivity impairment (TWPI) (N = 1) Total activity impairment (TAI) (N = 1) |
|
| Economic burden |
Direct costs (N = 1) Direct Costs of AD: medications, over-the-counter costs, medical testing and procedure expenses, physician visits, out-of-pocket expenses, transportation, and childcare increased as severity of AD worsened (N = 1) Indirect Costs of AD (productivity loss of caregivers) (N = 1) Lost productivity (N = 1) |
|
| Physical | Disease severity |
Psoriasis Area and Severity Index (PASI) (N = 16) Psoriasis Disability Index (PDI) (N = 3) Vitiligo area scoring index (VASI) (N = 1) Distress Thermometer (DT) (N = 1) Physician global assessment (PGA) (N = 1) Severity scoring of AD (SCORAD) (N = 1) Physicians Global Assessment (PGA) score (N = 1) Hand eczema severity:10-point visual analogue scale (VAS) (N = 1) Patient-Oriented Scoring Atopic Dermatitis (PO-SCORAD) index (N = 1) Impact of chronic Skin Disease on Daily Life (ISDL) (N = 1) Self-Administered Psoriasis Area and Severity Index (SAPASI) (N = 1) |
| Clinical feature |
Itching/pruritus: Visual Analogue Scale (VAS) (N = 2) Juckreiz-Kognitions-Fragebogen questionnaire (N = 1) SCORAD index (N = 1) |
|
| Distribution and extent |
Body Surface Area (BSA) (N = 6) Body surface involvement (N = 1) |
|
| Others | Sexual life |
Massachusetts General Hospital-Sexual Functioning Questionnaire (MGH-SFQ) (N = 2) Female Sexual Function Index (FSFI) (N = 1) International Index of Erectile Function (IIEF) (N = 1) |
| Stress |
Psoriasis Life Stress Inventory (PLSI) (N = 1) Stress Self-assessment Scale (N = 1) |
|
| Personality |
Eysenck Personality Questionnaire (EPQ) (N = 1) Eysenck Personality Inventory (N = 1) |
|
| Life course |
Course of life questionnaire (COLQ) (N = 1) Modified psoriasis life stress inventory (N = 1) |
|
| Loneliness | UCLA loneliness scale (UCLA-Version 3) (N = 1) | |
| Sleep Quality | Medical Outcomes Study Sleep Scale (MOS-SS) (N = 1) | |
| Disease control | Urticaria Control Test (UCT) (N = 1) | |
| Knowledge | Psoriasis Knowledge Assessment Questionnaire (N = 1) | |
| Biological Markers | CRP and cytokines IL-1β, IL-6, TNFα, and IL-17 (N = 1) | |
| Mindfulness | Five Facet Mindfulness Questionnaire (N = 1) |